-
Regarding the public solicitation of "Chemical Generic Drug Reference Preparation List (52nd Batch)"
Time of Update: 2021-12-01
Drug Evaluation Center of the State Drug Administration November 18, 2021 Relevant attachments Serial number accessory name 1 "Catalog of Reference Preparations of Chemical Generic Drugs (52nd Batch)" (Draft for Solicitation of Comments).
docx 2 Application Form for Objection to Chemical Generic Drug Reference Preparation.
-
AI predicts the animals most likely to spread the new coronavirus
Time of Update: 2021-12-01
However, the ACE2 protein of different species is different, so knowing the degree of binding of its ACE2 protein to the coronavirus spike protein can help predict which animals are most likely to infect and spread the new coronavirus .
-
Heal without medicine?
Time of Update: 2021-12-01
The world's second case of self-healing AIDS appears Science and Technology Daily, Beijing, November 17 (intern reporter Zhang Jiaxin) Recently, the research team of immunologist Xu Yu from Harvard University and MIT's Lagon Institute of Medicine discovered a second case of HIV that healed itself without treatment ( HIV) infected persons .
-
High risk of death after flu and new crown co-infection
Time of Update: 2021-12-01
Zhang Yonghui said that autumn and winter are periods of high incidence of respiratory infectious diseases, and the prevention and control of influenza, pneumonia, chickenpox, mumps and other diseases should be strengthened .
-
A total of 256,966,237 confirmed cases of new crowns worldwide
Time of Update: 2021-12-01
WHO: The global cumulative number of confirmed cases of new crown reached 256,966,237 WHO: The global cumulative number of confirmed cases of new crown reaches 256,966,237 WHO: The global cumulative number of confirmed cases of new crown reaches 256,966,237 Xinhua News Agency, Geneva, November 22 (Reporter Liu Qu) The latest data released by the World Health Organization on the 22nd showed that the total number of confirmed cases of new crown in the world reached 256,966,237 .
-
CDE Announcement on Issuing the "Technical Guidelines for Clinical Trials of Generic Drugs for Oral Inhalation Drugs that have been Marketed Abroad and Domestically Unmarketed"
Time of Update: 2021-12-01
45 of 2021) Release Date: 20211119 In order to further guide the scientific and reasonable development of generic drugs for oral inhalation preparations, under the deployment of the National Medical Products Administration, the Center for Drug Evaluation organized the formulation of the "Guidelines for the Clinical Trial of Generic Drugs for Oral Inhalation Preparations (Trial Implementation) )" (see attachment) .
-
National Food and Drug Administration Approves New Therapy for Multiple Myeloma
Time of Update: 2021-12-01
Studies have shown that for newly diagnosed multiple myeloma patients who are not suitable for autologous stem cell transplantation, a combination therapy based on daratumumab can significantly reduce the risk of disease progression or death, and prolong the progression-free survival of patients .
-
The delta variant is still the dominant strain of the epidemic, and its subtype is more terrifying?
Time of Update: 2021-12-01
Among the confirmed cases of new crown in most countries, the number of infected delta variant strains far exceeds other variant strains .
-
Israeli study says colchicine can help reduce COVID-19 mortality
Time of Update: 2021-12-01
Israeli study says colchicine can help reduce COVID-19 mortality Israeli study says colchicine helps reduce death rate from new crownsIsrael study says colchicine helps reduce death rate Xinhua News Agency, Jerusalem, November 21 (Reporter Lv Yingxu Shanghao) The Hebrew University of Israel published the results of a study on its website on the 21st, showing that the use of colchicine to treat severely ill patients with new crowns can help reduce the death rate of new crowns .
-
2.863 billion yuan was raised!
Time of Update: 2021-12-01
According to the data, Zejing Pharmaceutical is an innovation-driven chemical and biological new drug research and development and production enterprise focusing on multiple therapeutic fields such as tumors, bleeding and blood diseases, liver and gallbladder diseases, and immune inflammatory diseases .
-
Last week, 2 domestically produced Class 1 new drugs were approved for listing at the same time
Time of Update: 2021-12-01
Subcutaneous injection of PD-L1 antibody was approved for marketing in China On November 25, the National Medical Products Administration (NMPA) conditionally approved the listing of PD-L1 single domain antibody Envida® (Envolimab injection) .
-
Companies in the ophthalmic medical field continue to go public, and industry concentration will further increase
Time of Update: 2021-12-01
It is worth noting that while the ophthalmology medical market continues to expand, more and more companies are also increasing their layout in this field, trying to grab a piece of the pie .
In addition to Gaoshi Medical, in July this year, Chaoju Ophthalmology was also listed on the Hong Kong Stock Exchange.
-
Since the second half of this year, many pharmaceutical companies have gone bankrupt
Time of Update: 2021-12-01
For another example, recently, China Judgment Documents Network also announced a document concerning the application of Shaanxi Pharmaceutical Holdings Seoul Pharmaceutical Co.
applied to the court for bankruptcy liquidation of Shaanxi Pharmaceutical Holding Seoul Pharmaceutical Co.
-
Chinese experts take the lead in realizing accurate ultra-low anus preservation for patients with rectal cancer
Time of Update: 2021-12-01
The reporter learned on the 13th that the team of Professor Liu Zhongchen from Shanghai Tenth People's Hospital has successfully developed a new technique for anus-preserving surgery for ultra-low rectal cancer after 10 years .
-
Notice on the solicitation of research institutes for general inspection methods for seal integrity of national pharmaceutical packaging materials standards
Time of Update: 2021-12-01
Units intending to undertake research tasks need to fill in the "National Pharmaceutical Packaging Material Standard-General Testing Method for Seal Integrity Research Unit Application Form" (see Annex 2) .
National Pharmaceutical Packaging Material Standard-Application Form of Research Unit for General Testing Methods for Seal Integrity.
-
Health Commission: 75 newly diagnosed cases of 18 cases imported from abroad on the 12th
Time of Update: 2021-12-01
As of 24:00 on November 12, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1309 confirmed cases (including 21 severe cases), 92229 cured and discharged cases, and 4636 deaths.
-
Health Commission: Newly confirmed 62 cases of imported 19 cases overseas on the 8th
Time of Update: 2021-12-01
As of 24:00 on November 8, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1,222 confirmed cases (including 27 severe cases), a total of 92,027 cured and discharged cases, and a total of 4,636 deaths.
-
NIFDC: "Manual of Reference Materials for Pharmaceutical Excipients and Packaging Materials" compiled and issued by the Excipients and Packaging Materials Institute
Time of Update: 2021-12-01
It provides a list of reference materials for pharmaceutical excipients and pharmaceutical packaging materials of the China National Inspection and Quarantine Institute.
pdf Attachment download: Manual of Reference Materials for Pharmaceutical Excipients and Packaging Materials.
-
Why are the elderly macaques with new coronary pneumonia more severe?
Time of Update: 2021-12-01
Research reveals its immunopathological mechanism BEIJING, November 16 Kunming electric China Kexue Yuan Kunming Institute of Zoology, the official website 16 news release, the study team found that the new crown pneumonia aged rhesus monkey model of inflammatory response delay immunopathology mechanism outbreak .
-
Basic introduction to American DMF
Time of Update: 2021-12-01
Classification of DMF Type I: production location and plant facilities, personnel Type Ⅱ: Intermediates, APIs and drugs Type Ⅲ: Packaging materials Type IV: auxiliary materials, coloring agents, spices, flavors and other additives Type V: Non-clinical data and clinical data The main content of DMF The DMF file declared by the pharmaceutical excipient manufacturer to the FDA belongs to Type IV .
